News from ikaria, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 19, 2014, 07:19 ET

Ikaria and Lee's Pharmaceutical Announce Strategic Partnership for the Registration and Commercialization of Ikaria's INOMAX® Total Care Package in the People's Republic of China, Hong Kong, Macau and Taiwan

 Ikaria, Inc. (through its INO Therapeutics subsidiary) and Lee's Pharmaceutical (HK) Limited today announced the signing of a strategic...

Jan 07, 2014, 10:17 ET

Ikaria® To Present At Biotech Showcase™ 2014

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs...

Apr 16, 2013, 10:17 ET

Ikaria® To Present At 2013 Bio Business Forum and International Convention

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs...

Nov 13, 2012, 10:17 ET

FDA Clears INOMAX® DSIR To Connect With Hospital Health Information Systems

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today...

Aug 07, 2012, 10:16 ET

Ikaria® To Present At Wedbush Securities 2012 Life Sciences Management Access Conference

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs...

Jun 12, 2012, 10:17 ET

Ikaria® To Present At 2012 BIO International Convention

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today...

Apr 24, 2012, 07:01 ET

LUCASSIN® Approved in Australia

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, announced today...

Apr 23, 2012, 19:01 ET

LUCASSIN® Approved in Australia

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, announced today...

Apr 11, 2012, 10:17 ET

Ikaria® Appoints Chief Medical Officer

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today...

Mar 21, 2012, 10:17 ET

FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today announced...

Feb 27, 2012, 10:17 ET

Ikaria® Completes Patient Enrollment in Pivotal Phase III Trial for Bronchopulmonary Dysplasia

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients, today...

Feb 06, 2012, 10:17 ET

Ikaria® to Present at 14th Annual BIO CEO & Investor Conference

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of...

Jan 23, 2012, 10:17 ET

FDA Grants Orphan Drug Designation to Ikaria® For Use of Inhaled Nitric Oxide in Pulmonary Arterial Hypertension

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients,...

Jan 04, 2012, 10:17 ET

Ikaria® to Present at Biotech Showcase™ 2012

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the...

Jan 03, 2012, 07:00 ET

Ikaria® Commences Global Registration Trial for Bioabsorbable Cardiac Matrix

 Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients in the...

Dec 22, 2011, 20:00 ET

Ikaria® Issues Notice of Completed Remediation for INOMAX® DS Drug-delivery System

 Ikaria, Inc. announced today that it has completed a remediation action for its INOMAX® DS drug-delivery systems related to a fretting...

Nov 08, 2011, 10:17 ET

Ikaria® to Present at 2011 Lazard Capital Markets Healthcare Conference

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of...

Oct 18, 2011, 10:17 ET

Ikaria® to Present at 2011 BIO Investor Forum

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies designed to address the significant needs of...

Oct 11, 2011, 08:17 ET

Ikaria® Names New Chief Financial Officer

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients in the hospital...

Sep 22, 2011, 09:05 ET

Ikaria® CEO Daniel Tasse Elected to PhRMA Board of Directors

Ikaria, Inc., a critical care company focused on developing and commercializing innovative therapies for critically ill patients in the hospital...